108 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
21 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
Intervention:
22 Recruiting Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
23 Recruiting Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
Condition: DOAC Eligible Subjects
Intervention: Device: TEG6s DOAC Cartridge
24 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
Condition: Non Valvular Atrial Fibrillation (nv AF)
Interventions: Drug: Non-exposed group;   Drug: Exposed group
25 Recruiting Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Conditions: Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot
Interventions: Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
26 Recruiting EUS-FNA for Patients Taking Anticoagulants Without Heparin Bridge
Condition: Endoscopic Ultrasonography-guided Fine Needle Aspiration
Intervention: Procedure: Endoscopic ultrasonography-guided fine needle aspiration
27 Recruiting The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
Condition: Recurrent Pregnancy Loss
Interventions: Drug: Aspirin;   Drug: Heparin;   Drug: Prednisone;   Drug: Immunoglobulin;   Drug: Dydrogesterone
28 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
Intervention:
29 Not yet recruiting Treatment Pattern of Oral Anticoagulants (OAC) in Japan
Condition: Atrial Fibrillation
Intervention:
30 Recruiting PGE1 as Additive Anticoagulant in ECMO-Therapy
Conditions: Respiratory Distress Syndrome, Adult;   Extracorporeal Membrane Oxygenation
Interventions: Drug: Alprostadil;   Drug: 0.9% sodium chloride solution
31 Recruiting ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)
Condition: Diabetes
Interventions: Drug: Dabigatran;   Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Edoxaban;   Drug: Warfarin;   Drug: Acenocumarole
32 Recruiting Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
Condition: Benign Prostatic Hyperplasia
Intervention:
33 Recruiting Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
Condition: Atrial High Rate Episodes
Interventions: Drug: Edoxaban;   Drug: ASA
34 Recruiting Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism
Conditions: Pulmonary Embolism;   Intermediate-high Risk;   Combination of Oral Anticoagulation Therapy and Sildenafil
Interventions: Drug: Sildenafil/apixaban;   Drug: apixaban
35 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
36 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
37 Not yet recruiting COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
Conditions: Stable Angina;   Unstable Angina;   STEMI;   NSTEMI;   Coronary Disease
Interventions: Device: COMBO-Stent;   Drug: Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran;   Device: Any drug eluting stent oder bare metal sent;   Drug: ASA, Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
38 Recruiting Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions
Condition: Percutaneous Coronary Intervention
Intervention: Other: the prevalence of ischemic events
39 Recruiting Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)
Condition: Intra Operative Bleeding, Blood Salvage
Interventions: Drug: ACD-A;   Drug: Heparin
40 Recruiting Use of Public Health Surveillance Models in the French National Health System Database
Conditions: Atrial Fibrillation;   Anticoagulants;   Pharmacoepidemiology
Intervention: Drug: Dabigatran

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.